NCT06662227 2026-01-20Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell TumorsWondercel Biotech (ShenZhen)Phase EARLY_PHASE1 Recruiting30 enrolled
NCT05779930 2025-08-15Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHLNationwide Children's HospitalPhase EARLY_PHASE1 Not yet recruiting12 enrolled